<SEC-DOCUMENT>0001213900-26-018504.txt : 20260219
<SEC-HEADER>0001213900-26-018504.hdr.sgml : 20260219
<ACCEPTANCE-DATETIME>20260219171730
ACCESSION NUMBER:		0001213900-26-018504
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260213
FILED AS OF DATE:		20260219
DATE AS OF CHANGE:		20260219

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Caragol William J
		CENTRAL INDEX KEY:			0001380465
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41010
		FILM NUMBER:		26655651

	MAIL ADDRESS:	
		STREET 1:		1690 SOUTH CONGRESS AVENUE
		STREET 2:		SUITE 200
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAINZ BIOMED N.V.
		CENTRAL INDEX KEY:			0001874252
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ROBERT KOCH STRASSE 50
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55129
		BUSINESS PHONE:		49 6131 5542860

	MAIL ADDRESS:	
		STREET 1:		ROBERT KOCH STRASSE 50
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55129

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mainz Biomed B.V.
		DATE OF NAME CHANGE:	20210721
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2026-02-13</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001874252</issuerCik>
        <issuerName>MAINZ BIOMED N.V.</issuerName>
        <issuerTradingSymbol>MYNZ</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001380465</rptOwnerCik>
            <rptOwnerName>Caragol William J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>MAINZ BIOMED N.V.</rptOwnerStreet1>
            <rptOwnerStreet2>ROBERT KOCH STRASSE 50</rptOwnerStreet2>
            <rptOwnerCity>MAINZ</rptOwnerCity>
            <rptOwnerState>FL</rptOwnerState>
            <rptOwnerZipCode>55129</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Ordinary Shares</value>
            </securityTitle>
            <transactionDate>
                <value>2026-02-13</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>290000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>367899</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid.</footnote>
        <footnote id="F2">77,899 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ William Caragol</signatureName>
        <signatureDate>2026-02-19</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
